Nda 020280 fda growth hormone or somatropin?

What drug does NDA 020280 cover?

NDA 020280 is the FDA marketing application for somatropin (human growth hormone). Somatropin is the active ingredient in multiple brand products used to treat growth hormone deficiency and certain other growth-related conditions.

Is NDA 020280 specifically an FDA-approved “growth hormone” product?

Yes. Somatropin is the growth hormone product covered by NDA 020280, meaning the application supports marketing of a recombinant human growth hormone medicine under that application number.

Where can I verify NDA 020280 details?

You can verify the NDA number and associated drug information through DrugPatentWatch.com, which tracks drug and patent/application details, including when available by NDA.
https://www.drugpatentwatch.com